Testing Status of Tolazamide 10928-E
CASRN: 1156-19-0
Formula: C14-H21-N3-O3-S
Synonyms/Common Names
- N-(((Hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methylbenzenesulfonamide (9CI)
Short-Term Toxicity
- 14-Day (Dosed-Feed)
(C03327)
Completed
- Rats: F344/N; Mice: B6C3F1
- 13-Week (Dosed-Feed)
(C03327)
Completed
- Rats: F344/N; Mice: B6C3F1
- Dose: FR: 0, 2500, 40000, FM: 0, 2000, 50000 PPM/5 PER GROUP.
Long-Term Carcinogenicity
- 2-Year (Dosed-Feed)
(C03327)
Completed
- TR-051 (NIH Number: 78-1301)
(Peer Review Approval 03/06/1978A )
Bioassay of Tolazamide for Possible Carcinogenicity (CASRN 1156-19-0) - Rats: F344/N; Mice: B6C3F1
- Carcinogenesis Results
- Male Rats Negative
- Female Rats Negative
- Male Mice Negative
- Female Mice Negative
- Dose: 0, 5000, 10000 PPM/35 PER GROUP.
- TR-051 (NIH Number: 78-1301)
(Peer Review Approval 03/06/1978A )
Genetic Toxicology
- In Vitro Cytogenetics (CA/SCE)
(225955)
Completed
- Sister Chromatid Exchange Negative
- Chromosome Aberrations Negative
- Mouse Lymphoma
(255587)
Completed
- Mice
- Negative
- Salmonella
(352518)
Completed
- Citation: Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelmans, K. Salmonella mutagenicity tests. IV. Results from the testing of 300 chemicals Environ. Molec. Mutagen. Vol. 11 (Suppl 12) (1988) 1-158
- Equivocal